CULLINAN THERAPEUTICS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2020 | $14.4M | $214.7M | $168.2M |
| Mar 2021 | $10.0M | $479.7M | $293.5M |
| Jun 2021 | $5.8M | $464.4M | $123.7M |
| Sep 2021 | $7.9M | $453.4M | $88.1M |
| Dec 2021 | $11.8M | $437.2M | $59.8M |
| Mar 2022 | $18.0M | $437.5M | $76.1M |
| Jun 2022 | $62.6M | $667.2M | $353.6M |
| Sep 2022 | $31.1M | $617.2M | $242.7M |
| Dec 2022 | $26.1M | $561.1M | $156.2M |
| Mar 2023 | $29.3M | $515.0M | $122.1M |
| Jun 2023 | $22.4M | $522.0M | $141.8M |
| Sep 2023 | $25.9M | $494.7M | $64.8M |
| Dec 2023 | $30.3M | $484.2M | $98.4M |
| Mar 2024 | $23.8M | $449.4M | $74.2M |
| Jun 2024 | $25.0M | $681.2M | $115.0M |
| Sep 2024 | $25.4M | $653.3M | $102.1M |
| Dec 2024 | $31.5M | $621.8M | $83.0M |
| Mar 2025 | $27.8M | $579.7M | $76.7M |
| Jun 2025 | $28.2M | $520.3M | $72.8M |
| Sep 2025 | $32.8M | $484.1M | $103.3M |
| Dec 2025 | $39.6M | $448.4M | $88.3M |
| Mar 2026 | $36.8M | $403.0M | $75.1M |
| Jun 2026 | $42.0M | $363.8M | $78.6M |